234 related articles for article (PubMed ID: 22674796)
41. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
42. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.
Shi Y; Wang E
Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689
[TBL] [Abstract][Full Text] [Related]
43. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
[TBL] [Abstract][Full Text] [Related]
44. Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia.
Cavazzini F; Campioni D; Ferrari L; Buldini B; Bardi MA; Michielotto B; Lazzari MC; Ongari M; Dabusti M; Daghia G; Sofritti O; Basso G; Lanza F; Cuneo A
Cytometry B Clin Cytom; 2016 May; 90(3):247-56. PubMed ID: 26102234
[TBL] [Abstract][Full Text] [Related]
45. Differentiation of acute and chronic myeloid leukemic blasts into the dendritic cell lineage: analysis of various differentiation-inducing signals.
Kharfan-Dabaja M; Ayala E; Lindner I; Cejas PJ; Bahlis NJ; Kolonias D; Carlson LM; Lee KP
Cancer Immunol Immunother; 2005 Jan; 54(1):25-36. PubMed ID: 15693136
[TBL] [Abstract][Full Text] [Related]
46. [Blastic plasmacytoid dendritic cell neoplasm - a rare differential diagnosis of neoplastic skin infiltrations associated with systemic symptoms].
Löffler H; Kosely F; Ho AD; Krämer A
Dtsch Med Wochenschr; 2009 Sep; 134(39):1927-30. PubMed ID: 19760552
[TBL] [Abstract][Full Text] [Related]
47. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
48. Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm.
Wang W; Xu J; Khoury JD; Pemmaraju N; Fang H; Miranda RN; Yin CC; Hussein SE; Jia F; Tang Z; Hu S; Konopleva M; Medeiros LJ; Wang SA
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884435
[TBL] [Abstract][Full Text] [Related]
49. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis.
Knapp W; Strobl H; Majdic O
Cytometry; 1994 Dec; 18(4):187-98. PubMed ID: 7534675
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the leukocyte differential on a new automated flow cytometry hematology analyzer.
Kim JE; Kim BR; Woo KS; Han JY
Int J Lab Hematol; 2012 Oct; 34(5):547-50. PubMed ID: 22591170
[TBL] [Abstract][Full Text] [Related]
51. [Expression of CD66c (CEACM6) in adult acute leukemia and its significance].
Chen BG; Yan WH; Meng ZF; Guo ZM; Zhu M; Li BL
Zhonghua Xue Ye Xue Za Zhi; 2006 Jun; 27(6):370-3. PubMed ID: 17147224
[TBL] [Abstract][Full Text] [Related]
52. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
53. Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia.
Guy J; Antony-Debré I; Benayoun E; Arnoux I; Fossat C; Le Garff-Tavernier M; Raimbault A; Imbert M; Maynadié M; Lacombe F; Béné MC; Wagner-Ballon O;
Br J Haematol; 2013 May; 161(4):551-5. PubMed ID: 23432206
[TBL] [Abstract][Full Text] [Related]
54. Blastic plasmacytoid dendritic cell neoplasm: is it time to redefine the standard of care?
Piccaluga PP; Paolini S; Sapienza MR; Pileri SA
Expert Rev Hematol; 2012 Aug; 5(4):353-5. PubMed ID: 22992228
[No Abstract] [Full Text] [Related]
55. Intracellular IL-4, IL-10, and IFN-gamma levels of leukemic cells and bone marrow T cells in acute leukemia.
Park HH; Kim M; Lee BH; Lim J; Kim Y; Lee EJ; Min WS; Kang CS; Kim WI; Shim SI; Han K
Ann Clin Lab Sci; 2006; 36(1):7-15. PubMed ID: 16501231
[TBL] [Abstract][Full Text] [Related]
56. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.
Carulli G; Petrini M; Marini A; Vaglini F; Caracciolo F; Grassi B
Haematologica; 1990; 75(6):516-21. PubMed ID: 1982999
[TBL] [Abstract][Full Text] [Related]
57. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
Al-Mawali A; Gillis D; Hissaria P; Lewis I
Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of diagnostic efficacy of NRP-1/CD304 in hematological diseases.
Liu YJ; Li XH; Song YL; Zhou YC; Cai RZ; Chi PD
Cancer Med; 2023 May; 12(10):11284-11292. PubMed ID: 36965095
[TBL] [Abstract][Full Text] [Related]
59. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin.
Herling M; Teitell MA; Shen RR; Medeiros LJ; Jones D
Blood; 2003 Jun; 101(12):5007-9. PubMed ID: 12576313
[TBL] [Abstract][Full Text] [Related]
60. CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping.
Bras AE; de Haas V; van Stigt A; Jongen-Lavrencic M; Beverloo HB; Te Marvelde JG; Zwaan CM; van Dongen JJM; Leusen JHW; van der Velden VHJ
Cytometry B Clin Cytom; 2019 Mar; 96(2):134-142. PubMed ID: 30450744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]